Randomized clinical trials (RCTs) in pediatric multiple sclerosis: Are they really necessary?

Abstract

Get full access to this article

View all access options for this article.

References

Hintzen

. Clinical trials for pediatric MS should be prioritized to test only one or two of the most promising agents – Commentary. Mult Scler J 2016; 22(13): 1653–1654.

Chitnis

Ghezzi

Kornek

. Pediatric multiple sclerosis: Escalation and emerging treatments. Neurology 2016; 87(Suppl. 2): S103–S109.

Ghezzi

Banwell

Boyko

. The management of multiple sclerosis in children: A European view. Mult Scler 2010; 16(10): 1258–1267.

Amit Bar-Or

Hintzen

Dale

. Immunopathophysiology of pediatric CNS inflammatory demyelinating diseases. Neurology 2016; 87(Suppl. 2): S12–S19.

Verhey

Signori

Arnold

. Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials. Neurology 2013; 81(14): 1215–1221.